Pharmacy Medical News about Haemodialysis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis: An Open-Label, Single-Centre Study
Clinical Drug Investigation, 10/15/09

Schulz EG et al. – In this study with small number of patients with ERF undergoing haemodialysis, candesartan cilexetil was effective in lowering BP and pulse pressure without accumulation or associated adverse effects such as elevated potassium or symptomatic hypotension.

<< Previous
Anthracycline- and/or taxane-resistant breast cancer: Results of...

Next >>
An evidence-based assessment of the clinical significance of...

Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patients
BMC Nephrology, 10/27/09 Relevance Score: 88%

The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit
Nephrology Dialysis Transplantation, 11/05/09 Relevance Score: 85%

Effects of thermal therapy on uremic pruritus and biochemical parameters in patients having haemodialysis
Journal of Advanced Nursing, 11/05/09 Relevance Score: 84%

Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production
Nephrology Dialysis Transplantation, 11/17/09 Relevance Score: 83%

Evaluation of Oxidant-Antioxidant Balance in Patients on Maintenance Haemodialysis: A Comparative Study of Dialyzers Membranes
Nephron: Clinical Practice, 10/12/09 Relevance Score: 83%